Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The Global Anti-Obesity Drug Market is estimated to be valued at USD 30.58 Bn in 2026 and is expected to reach USD 98.63 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 18.2% from 2026 to 2033
It was originally derived from a protective gastric peptide sequence, and much of the research has focused on mucosal protection, ulcer healing, intestinal inflammation, and gut barrier support
In the same month, Viatris agreed to acquire Oyster Point Pharma and Famy Life Sciences for an aggregate of $700 million to 750 million to create an ophthalmology division, with the acquisitions closing in January 2023
Researchers can assess the stability and compatibility of the drug within the receptor
GLP-1 analogues are often prescribed for chronic conditions such as type 2 diabetes and obesity, which require ongoing, long-term management
Holz, G
US$ 20.29
US$ 20.82
US$ 20.35
US$ 21.07
.png)
US$ 26.01
